Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SPR994
SPR994
Shooting for PhIII, Spero tees up a new lead antibiotic in-licensed cheap as it lines up $86M IPO
Endpoints
Wed, 10/11/17 - 10:00 am
Spero
antibiotics
clinical trials
Orapenem
SPR994